Nobivac® FeLV

NOBIVAC® FELV

Cats

Diseases

Feline Class

>Vaccines – 2-year immunity

Nobivac® FeLV





Biological name
Feline Leukemia Vaccine, KILLED VIRUS



The only vaccine with proven 2-year duration of immunity for feline leukemia virus (FeLV).1

Features and benefits


A quality core vaccine that protects against feline leukemia
  • The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination2
  • 96% of vaccinated cats were protected against persistent viremia after FeLV challenge1
  • In a 2-year study involving 23 FeLV-negative cats:2
    • After 12 weeks, 83% of vaccinates were free of persistent and transient viremia
    • All 11 control cats (100%) developed persistent viremia
    • Results showed that cats developed immunity solely through the initial vaccination series
  • Available in combination with other Nobivac® feline vaccines to provide broader disease protection
  • Optimal choice for healthy outdoor cats

Indication

  • Approved for the vaccination of healthy cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection
  • Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus
  • Recommended for use in healthy cats 9 weeks of age or older

Safety information

  • 99.99% reaction-free in ongoing surveillance involving millions of doses1
  • Two-year duration of immunity means fewer vaccinations

Please see the product label for further safety information.

Dosage and administration

For cats 9 weeks of age or older:

  • Subcutaneous or intramuscular injection
  • Initial 1-mL dose administered at 9 weeks of age or older
  • Second 1-mL dose administered 3 to 4 weeks later
  • Revaccination every 2 years with a single dose is recommended

For further information, including complete directions and warnings, please see the product label.

Product label(s) and MSDS

References:

  1. Data on file, Merck Animal Health.
  2. Jirjis FF, Davis T, Lane J, et al. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine. Vet Ther. 2010;11(2):E1–E6.
TRUSTe European Safe Harbor certification
Validate TRUSTe privacy certification